Memphis Pharmaceuticals & Chemical Industries reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was EGP 429.79 million compared to EGP 302.65 million a year ago. Net income was EGP 82.89 million compared to EGP 27.56 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
72.96 EGP | -0.03% | -5.10% | +16.35% |
1st Jan change | Capi. | |
---|---|---|
+16.35% | 8.6M | |
+40.95% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.45% | 246B | |
-0.08% | 225B | |
+10.32% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2023